Images List Premium Download Classic

G Protein

G Protein-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Assessing retinal pigment epithelial cell populations
Cell Cure Neurosciences Ltd.
January 11, 2018 - N°20180011092

A method of qualifying whether a cell population is a suitable therapeutic for treating an eye condition is disclosed. The method comprises analyzing co-expression of premelanosome protein (pmel17) and at least one polypeptide selected from the group consisting of cellular retinaldehyde binding protein (cralbp), lecithin retinol acyltransferase (lrat) and sex determining region y-box 9 (sox 9) in the population of cells.
Novel dna-binding proteins and uses thereof
Sangamo Therapeutics, Inc.
January 11, 2018 - N°20180010152

Disclosed herein are polypeptides, polynucleotides encoding, cells and organisms comprising novel dna-binding domains, including tale dna-binding domains. Also disclosed are methods of using these novel dna-binding domains for modulation of gene expression and/or genomic editing of endogenous cellular sequences.
Nanocapsules carrying chikungunya-associated peptides
Nanyang Technological University
January 11, 2018 - N°20180008690

The present invention refers to a composition comprising a viral protein or fragment thereof, wherein the viral protein or fragment thereof is enclosed within a self-assembling protein nanocapsule, preferably ferritin, and wherein the viral protein, or fragment thereof is selected from a virus of the togaviridae family. The viral protein or fragment thereof may also further be selected from a ...
G Protein Patent Pack
Download 625+ patent application PDFs
G Protein Patent Applications
Download 625+ G Protein-related PDFs
For professional research & prior art discovery
inventor
  • 625+ full patent PDF documents of G Protein-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods of treating retinal diseases
Cell Cure Neurosciences Ltd.
January 11, 2018 - N°20180008458

A method of treating a subject with dry-form age-related macular degeneration (amd) is disclosed. The method comprises administering into the subretina of the subject a therapeutically effective amount of a pharmaceutical composition comprising human rpe cells, wherein at least 95% of the cells thereof co-express premelanosome protein (pmel17) and cellular retinaldehyde binding protein (cralbp), wherein the trans-epithelial electrical resistance of the ...
Fortified snack foods and methods of fortification
Balanced Nutrients
January 11, 2018 - N°20180007928

Improved adhesion of powdered and particulate color and flavoring to dry snack foods such as, but not limited to: chips, pretzels, crackers, and puffed, popped, baked or extruded compositions is provided. The improved adhesive is a milk or water based composition with added high quality protein selected from one or more of milk, whey, milk concentrate, whey concentrate, isolated milk ...
Easily digestible chocolate product
Cavalier
January 11, 2018 - N°20180007927

The present invention concerns an easily digestible low sugar chocolate product for consumers with sensitivity to dietary carbohydrates such as lactose or fructans. In particular, the present invention concerns a composition for manufacturing a sweet tasting chocolate product that comprises less than 5%, or less than 2%, or even less than 1% poorly absorbable in the human small intestine fermentable oligo-, di-, monosaccharides, ...
G Protein Patent Pack
Download 625+ patent application PDFs
G Protein Patent Applications
Download 625+ G Protein-related PDFs
For professional research & prior art discovery
inventor
  • 625+ full patent PDF documents of G Protein-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions and methods for protein glycosylation
Glaxosmithkline Biologicals, Sa
January 04, 2018 - N°20180002679

Described herein are oligosaccharyl transferases for use in n-glycosylating proteins of interest in vitro and in host cells. Methods for using such oligosaccharyl transferases, nucleic acids encoding such oligosaccharyl transferases, and host cells comprising such oligosaccharyl transferases are also provided herein. Glycoconjugates generated by using such oligosaccharyl transferases are also provided herein.
Use of adenovirus and nucleic acids coding therefor
Glaxosmithkline Biologicals, Sa
January 04, 2018 - N°20180002674

This invention relates to the use of an adenovirus to treat cancer, for example. The adenovirus may be replication deficient in cells that lack y box binding protein. The adenovirus may encode an oncogene or an oncogene product, which may transactivate at least one viral gene.
Plasma kallikrein binding proteins
Dyax Corp.
January 04, 2018 - N°20180002449

Plasma kallikrein binding proteins and methods of using such proteins are described.
Plasma kallikrein binding proteins
Dyax Corp.
January 04, 2018 - N°20180002448

Plasma kallikrein binding proteins and methods of using such proteins are described.
Plasma kallikrein binding proteins
Dyax Corp.
January 04, 2018 - N°20180002447

Plasma kallikrein binding proteins and methods of using such proteins are described.
Antibodies to matrix metalloproteinase 9
Gilead Biologics, Inc.
January 04, 2018 - N°20180002446

The present disclosure provides compositions and methods of use involving binding proteins, e. G., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (mmp9) protein (mmp9 is also known as gelatinase-b), such as where the binding proteins comprise an immunoglobulin (ig) heavy chain (or functional fragment thereof) and an ig light chain (or functional fragment thereof).
Oncostatin m receptor antigen binding proteins
Kiniksa Pharmaceuticals, Ltd.
January 04, 2018 - N°20180002429

The invention provides anti-oncostatin m receptor-β (osmr) antigen binding proteins, e. G., antibodies and functional fragments, derivatives, muteins, and variants thereof. Osmr antigen binding proteins interfere with binding of osm and/or il-31 to osmr. In some embodiments, anti-osmr antigen binding proteins are useful tools in studying diseases and disorders associated with osmr and are particularly useful in ...
G Protein Patent Pack
Download 625+ patent application PDFs
G Protein Patent Applications
Download 625+ G Protein-related PDFs
For professional research & prior art discovery
inventor
  • 625+ full patent PDF documents of G Protein-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Early marker of proteinuria in patients treated with an anti-vegf treatment
Mayo Foundation For Medical Education And Research
January 04, 2018 - N°20180002416

This document provides methods and materials related to determining whether or not a human receiving a therapy (e. G., an anti-vegf therapy such as a bevacizumab therapy) has developed or is at risk for developing proteinuria. For example, methods and materials for detecting urinary podocytes to determine whether or not a human receiving anti-vegf therapy has or is at risk ...
Method for selecting a single cell expressing a heterogeneous combination of antibodies
Merus N.v.
January 04, 2018 - N°20180002405

The present invention provides combinations of specific binding proteins, such as immunoglobulins, that are designed to be true combinations, essentially all components of the combination being functional and compatible with each other. The invention further provides a method for producing a composition comprising at least two different proteinaceous molecules comprising paired variable regions, the at least two proteinaceous molecules having ...
Method for selecting a single cell expressing a heterogeneous combination of antibodies
Merus N.v.
January 04, 2018 - N°20180002404

The present invention provides combinations of specific binding proteins, such as immunoglobulins, that are designed to be true combinations, essentially all components of the combination being functional and compatible with each other. The invention further provides a method for producing a composition comprising at least two different proteinaceous molecules comprising paired variable regions, the at least two proteinaceous molecules having ...
High-sensitive fluorescent energy transfer assay using fluorescent amino acids and fluorescent proteins
The Regents Of The University Of California
December 28, 2017 - N°20170370916

The disclosure provides method and composition utilizing fluorescent amino acids and fluorescent proteins comprising a moiety capable of undergoing fret. The methods and compositions of the disclosure are useful in analyzing protein structure and function, and screening molecular inhibitors.
Gene expression system using stealthy rna, and gene introduction/expression vector including said rna
Tokiwa-bio Inc.
December 28, 2017 - N°20170369903

Simultaneous expression of a plurality of foreign genes by using a stealthy rna gene expression system that is a complex that does not activate the innate immune mechanism and is formed from an rna-dependent rna polymerase, a single-strand rna binding protein, and negative-sense single-strand rnas including the following (1) to (8): (1) a target rna sequence that codes for any protein or functional ...
Therapeutic compositions for breast cancer containing protein kinase d1 inhibitor
Sookmyung Women's University Industry Academic Cooperation Foundation
December 28, 2017 - N°20170369887

A method of inhibiting the growth of cancer stem cells, including administering an effective amount of a protein kinase d1 expression or activity inhibitor as an active ingredient to a subject having cancer is provided. Further, a method of treating cancer, including administering an effective amount of a protein kinase d1 expression or activity inhibitor, and antitumor agent as active ...
Feed media
Amgen Inc.
December 28, 2017 - N°20170369837

The invention provides stable feed media containing pyruvate and methods for stabilizing feed media by adding pyruvate. The invention further provides methods for producing proteins using such media and proteins produced through the use of such methods.
Mice expressing a limited immunoglobulin light chain repertoire
Regeneron Pharmaceuticals, Inc.
December 28, 2017 - N°20170369593

A genetically modified mouse is provided, wherein the mouse expresses an immunoglobulin light chain repertoire characterized by a limited number of light chain variable domains. Mice are provided that present a choice of two human light chain variable gene segments such that the immunoglobulin light chains expresses by the mouse comprise one of the two human light chain variable gene ...
Loading